PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VRTX vs. BX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


VRTXBX
YTD Return-2.31%-5.73%
1Y Return17.12%45.35%
3Y Return (Ann)22.66%15.62%
5Y Return (Ann)18.14%29.49%
10Y Return (Ann)19.43%21.55%
Sharpe Ratio0.971.58
Daily Std Dev23.69%30.69%
Max Drawdown-91.77%-87.65%
Current Drawdown-10.89%-10.17%

Fundamentals


VRTXBX
Market Cap$102.73B$149.16B
EPS$13.87$2.84
PE Ratio28.6643.13
PEG Ratio0.531.75
Revenue (TTM)$9.87B$9.93B
Gross Profit (TTM)$5.32B$7.05B

Correlation

-0.50.00.51.00.3

The correlation between VRTX and BX is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

VRTX vs. BX - Performance Comparison

In the year-to-date period, VRTX achieves a -2.31% return, which is significantly higher than BX's -5.73% return. Over the past 10 years, VRTX has underperformed BX with an annualized return of 19.43%, while BX has yielded a comparatively higher 21.55% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


600.00%800.00%1,000.00%1,200.00%1,400.00%1,600.00%NovemberDecember2024FebruaryMarchApril
1,417.10%
786.65%
VRTX
BX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Vertex Pharmaceuticals Incorporated

The Blackstone Group Inc.

Risk-Adjusted Performance

VRTX vs. BX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and The Blackstone Group Inc. (BX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VRTX
Sharpe ratio
The chart of Sharpe ratio for VRTX, currently valued at 0.97, compared to the broader market-2.00-1.000.001.002.003.004.000.97
Sortino ratio
The chart of Sortino ratio for VRTX, currently valued at 1.69, compared to the broader market-4.00-2.000.002.004.006.001.69
Omega ratio
The chart of Omega ratio for VRTX, currently valued at 1.21, compared to the broader market0.501.001.501.21
Calmar ratio
The chart of Calmar ratio for VRTX, currently valued at 1.93, compared to the broader market0.002.004.006.001.93
Martin ratio
The chart of Martin ratio for VRTX, currently valued at 4.50, compared to the broader market0.0010.0020.0030.004.50
BX
Sharpe ratio
The chart of Sharpe ratio for BX, currently valued at 1.58, compared to the broader market-2.00-1.000.001.002.003.004.001.58
Sortino ratio
The chart of Sortino ratio for BX, currently valued at 2.14, compared to the broader market-4.00-2.000.002.004.006.002.14
Omega ratio
The chart of Omega ratio for BX, currently valued at 1.27, compared to the broader market0.501.001.501.27
Calmar ratio
The chart of Calmar ratio for BX, currently valued at 1.14, compared to the broader market0.002.004.006.001.14
Martin ratio
The chart of Martin ratio for BX, currently valued at 6.86, compared to the broader market0.0010.0020.0030.006.86

VRTX vs. BX - Sharpe Ratio Comparison

The current VRTX Sharpe Ratio is 0.97, which is lower than the BX Sharpe Ratio of 1.58. The chart below compares the 12-month rolling Sharpe Ratio of VRTX and BX.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50NovemberDecember2024FebruaryMarchApril
0.97
1.58
VRTX
BX

Dividends

VRTX vs. BX - Dividend Comparison

VRTX has not paid dividends to shareholders, while BX's dividend yield for the trailing twelve months is around 3.41%.


TTM20232022202120202019201820172016201520142013
VRTX
Vertex Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BX
The Blackstone Group Inc.
2.74%2.54%6.66%2.76%2.95%3.43%8.12%7.25%8.44%9.92%5.63%3.67%

Drawdowns

VRTX vs. BX - Drawdown Comparison

The maximum VRTX drawdown since its inception was -91.77%, roughly equal to the maximum BX drawdown of -87.65%. Use the drawdown chart below to compare losses from any high point for VRTX and BX. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-10.89%
-10.17%
VRTX
BX

Volatility

VRTX vs. BX - Volatility Comparison

The current volatility for Vertex Pharmaceuticals Incorporated (VRTX) is 4.45%, while The Blackstone Group Inc. (BX) has a volatility of 8.61%. This indicates that VRTX experiences smaller price fluctuations and is considered to be less risky than BX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2024FebruaryMarchApril
4.45%
8.61%
VRTX
BX

Financials

VRTX vs. BX - Financials Comparison

This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and The Blackstone Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items